Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 1998

View Archived Issues

U.S. patent to be issued for vaccine delivery system

Human Genome Sciences completes phase I trial of novel anticancer drug

Crystal structure of Entremed's Endostatin protein revealed

Gavestinel enters phase III; good phase II results in acute stroke reported

BRAINS: a phase II trial of Bay-x-3702 in ischemic stroke

Targeted NO donor enhances the activity of aspirin and heparin in preventing embolization

Preclinical safety of maxacalcitol reviewed in depth

Novel aromatase inhibitor discovered by French researchers

Electroporation therapy shows promise in preclinical models of human larynx tumors

Cel-Sci's improved AIDS vaccine recognizes most prevalent strains of virus

Efficacy of Ginkgo biloba extract in ED disproved in controlled clinical trial

Genzyme General and BioMarin join forces to develop product for genetic disorder

Bronchotherapeutic agents in development at Byk Gulden

Zadaxin shows efficacy and safety in phase III trial for hepatitis B

Dopamine agonists from AHP particularly useful in the treatment of schizophrenia

Lilly patents nonclassical antifolates for cancer, arthritis and psoriasis

Sodium channel modulators under evaluation at Takeda

Merck & Co. research leads to novel vitronectin antagonists for osteoporosis, cancer, etc.

Chinese herbal medicine reduces ALT levels in chronic hepatitis C

Posicor voluntarily withdrawn from the market

ProScript and Hoechst Marion Roussel extend antiinflammatory drug collaboration

Profile of activity of CGS-26582, a triple inhibitor of ECE, NEP and ACE

Yoshitomi terminates SomatoKine collaboration with Celtrix

Atacand: new antihypertensive agent approved for marketing in U.S.

Schering AG: Annual Report 1997

CAT's monoclonal antibody progresses in ophthalmic clinical trials

Astra Merck may undergo restructuring

Neuroprotective mechanism of pyrrolopyrimidine lipid peroxidation inhibitors

Elastin disruption leads to obstructive arterial disease

Zimmer and Anika expand Orthovisc agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...